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CASE STUDY
Paroxysmal sympathetic hyperactivity 
in brainstem-compressing huge benign tumors: 
clinical experiences and literature review
Seungjoo Lee1, Go Woon Jun2, Sang Beom Jeon3, Chang Jin Kim1 and Jeong Hoon Kim1*
Abstract 
Severe paroxysmal sympathetic overactivity occurs in a subgroup of patients with acquired brain injuries including 
traumatic brain injury, hypoxia, infection and tumor-related complications. This condition is characterized by sudden 
increase of heart rate, respiratory rate, blood pressure, body temperature and excessive diaphoresis. The episodes may 
be induced by external stimulation or may occur spontaneously. Frequent occurrence of this condition could result in 
secondary morbidities, therefore, should be diagnosed and managed insightfully. These symptoms could be confused 
with seizures or other medical conditions, leading to unnecessary treatment. Despite clinical significance of paroxys-
mal sympathetic hyperactivity (PSH), brain tumor-induced PSH has not been studied nearly. In this report, two cases 
of the PSH in patients with brainstem-compressing benign tumors were introduced. The most useful pharmacologic 
agents were opioid (e.g., fentanyl patch) in preventing PSH attack, and nonselective β-blocker (e.g., propranolol) in 
relieving the symptoms. Clinical experiences of the rare cases of benign tumor-induced PSH can be helpful as an 
essential basis for further research.
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Background
Episodes of acute sympathetic disturbances may occur 
after acquired brain injuries, such as traumatic brain 
injury, hypoxia, infection, and tumor-related compli-
cations (Baguley et  al. 2004; Baguley et  al. 2007). This 
condition could be misinterpreted as seizure, sepsis, 
metabolic disturbances because of clinical similarities 
with them. In patients with acquired brain injury, a par-
oxysmal sympathetic hyperactivity (PSH) characterized 
by sudden increase of heart rate, respiratory rate, blood 
pressure, body temperature, diaphoresis as well as exten-
sor posturing could be manifested (Meyer 2014), and had 
been termed as dysautonomia, diencephalic epilepsy, 
sympathetic storming, and autonomic dysfunction syn-
drome (Goddeau et  al. 2007; Rabinstein and Benarroch 
2008). Recently, a PSH has been used to describe the 
above conditions (Meyer 2014). Although the pathophys-
iology of the PSH is still elusive, the acquired brain inju-
ries involving brainstem have been revealed to cause the 
PSH (Follett et al. 2003; Soukup et al. 2002). The frequent 
episodes of PSH could result in secondary morbidities 
including increased intracranial pressure, cardiac dam-
age, and metabolic disturbances. Therefore, this condi-
tion should be diagnosed and managed insightfully (Reith 
et al. 1996; Thorley et al. 2001).
In this report, the rare cases of postoperative PSH 
in huge benign brain tumors compressing brainstem 
would be introduced, in addition, the clinical experi-




A 23-year old man was referred with symptoms of pro-
gressing left side hemiparesis (grade II) and intermit-
tent dystonic movements. In neurologic examination, he 
demonstrated alert mentality and his pupil was slightly 
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dilated and decreased light reflex in right side. In addi-
tion, it is also identified that the decreased swallowing 
function and dysarthria. A MRI scan showed an 8.1 cm-
sized calcified extraaxial mass over left middle and pos-
terior cranial fossa with petrosal apex epicenter. At the 
same time, the midbrain, pons, and left middle cerebral 
peduncle was compressed and deviated to right side 
(Fig. 1a). The patient underwent the surgery via the left 
transzygomatic subtemporal transtentorial approach 
and the tumor was subtotally removed due to the firm 
adhesion of tumor to the brainstem. In the postopera-
tive CT scan, focal hemorrhage and diffuse edematous 
change were observed in middle cerebral peduncle and 
brainstem (Fig. 1b). The level of consciousness of patient 
was stupor and sustained thereafter. The histopathologic 
diagnosis of this patient was chondrosarcoma consisting 
of cellular proliferation of small rounded chondrocytes 
and obvious well-formed hyaline cartilage (Fig. 2a–d).
At 23 days after surgery, it was often showed that the 
paroxysmal increase of heart rate, respiratory rate, blood 
pressure and extensor posturing responding to non-nox-
ious stimuli such as bathing and turning of body. These 
symptoms were repeated and lasted for several minutes 
and then, spontaneously subsided. This over-reactivity 
of sympathetic responses to external stimuli was mani-
fested as the increase of respiratory rate, heart rate, blood 
pressure and body temperature even diaphoresis (Fig. 3). 
The PSH was occurred suddenly, a literal meaning. The 
symptoms were onset response to non-noxious stimuli 
such as head turning, chest percussion or presented even 
without stimuli. The PSH was usually sustained within 
10–20  min and resolved spontaneously. These wax and 
wine pattern was repeated several times a day.
To exclude postoperative seizure, the electroencepha-
logram was continuously monitored, however, the epi-
leptiform discharges were not observed. Moreover, in 
spite of antiepileptic drugs (AEDs) were administrated 
and maintained within therapeutic level of concentra-
tion in blood, the paroxysmal sympathetic hyperactivi-
ties (PSH) were repeated. In blood chemistry, the level 
of glucose and electrolytes were within normal ranges. 
The inflammation markers, such as WBC, ESR, CRP, and 
lactic acid were also not significant. There were no active 
lung lesions on chest X-ray and urine analysis was also 
normal.
Initially, the beta antagonist (propranolol, 1  mg/kg/
day) and diazepam (2 mg/day) were tried under impres-
sion of PSH for several days, however, there was no 
effect in prevention of the PSH. The baclofen (10 mg/tid/
day) was added, but not effective. The opioid patch was 
applied and the occurrence of the PSH was gradually 
decreased over a week. After 10 days of the opioid patch 
Fig. 1 a. Preoperative radiologic imaging of patient 1 with PSH. Huge size (8.1 cm) extraaxial calcified mass over left middle cranial fossa and pos-
terior cranial fossa is compressing brainstem. This mass originates from petrosal apex and displaces midbrain, pons, and middle cerebellar peduncle 
to right side. (Clockwise direction; T2WI coronal, T1W enhance coronal, CT with enhance, T1W enhance axial). b. Postoperative (POD 20) CT scan 
showing residual calcified mass adjacent to brainstem and hemorrhage, edema in brainstem
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application, the PSH was not observed, however, abdom-
inal distention and constipation occurred. To relief the 
constipation, the opioid patch was removed, and then the 
PSH was recurred at 3 days after cessation of the patch. 
Therefore, the opioid patch (fentanyl propanamide, 
25  mcg/hr) was reapplied and PSH was subsided again. 
At same time, stool softner (magnesium oxide, 500 mg/
tid/day) and bowel motility drugs (domperidone, 10 mg/
tid/day) were administered and intermittent enema was 
also performed. The use of the opioid patch was tapered 
gradually after 1 week of reapplication, and the PSH was 
not recurred.
Case 2
A 30-year-old man was referred with stupor conscious-
ness from other hospital after primary surgery. He was 
diagnosed as the huge sized jugular foramen schwan-
noma with compressing brainstem (Fig.  4a). He already 
underwent the ventriculoperitoneal shunt to relief 
obstructive hydrocephalus and suboccipital craniotomy 
with partial decompression of the tumor. However, the 
residual mass was still huge and compressing the brain-
stem. He had been stupor with decreased brainstem 
reflex, such as light pupillary reflex, corneal and gag 
reflex.
The mass was subtotally removed via previous crani-
otomy site. The firmly adhesion lesion to brainstem was 
left, because of concerning about brainstem injury. In 
postoperative CT scan, it was observed the focal hem-
orrhage and mild edema in brainstem (Fig.  4b). His 
neurological status was not changed and maintained 
unrelievedly. In histopathology of this patient, the tumor 
composed entirely of neoplastic Schwann cells and form-
ing two basic patterns in varying proportion: areas of 
compact, elongated cells with occasional nuclear palisad-
ing (Antoni A pattern) and less cellular, loosely textured 
cells with variable lipidization (Antoni B pattern). Based 
on these findings, this patient was diagnosed schwan-
noma (Fig. 5).
At 2  weeks after surgery, the paroxysmal increase of 
the heart rate, respiratory rate and blood pressure was 
observed, as well as extensor posturing, reactive to bath-
ing or repositioning of the body. These symptoms were 
resolved spontaneously within several minutes. There 
were no significant findings in EEG, CT scan, and blood 
chemistry. The diazepam and baclofen were not effective 
in preventing the PSH, therefore, the opioid patch (fen-
tanyl propanamide, 25  mcg/hr) was applied. The PSH 
had been disappeared gradually over a week. The opioid 
Fig. 2 Histopathology of patient 1’s specimen (hematoxylin and eosin stain). Distinctly, there are abundant fibrous and chondroid matrix with 
formation of pink homogenous osteoid (Blue arrow, in a, b). Some areas of the tumor show obvious cartilaginous differentiation with well-formed 
hyaline cartilage (black arrow in a). Most areas of the tumor consist of cellular proliferation of small rounded chondrocytes (blue arrow in d). These 
cells are focally arranged in cords and trabeculae (c). Based on these findings, patient was diagnosed chondrosarcoma. (a, c: 40×, b, d: 100×)
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The distinctive clinical features of sudden increase 
of sympathetic activities responding to non-nox-
ious external stimuli have been described a wide 
range of labels, dysautonomia, sympathetic storming, 
hypothalamic-midbrain dysregulation syndrome, dien-
cephalic epilepsy, and paroxysmal sympathetic hyperac-
tivity (PSH) (Rabinstein 2004). Recent systemic reviews 
about this phenomena have been converged to the PSH 
because of well-delineation of clinical features such as 
increasing of heart rate (HR), respiratory rate (RR), blood 
pressure (BP), body temperature (BT), diaphoresis and 
extensor muscle tones (Table  1). In some cases, combi-
nations of sympathetic and parasympathetic overactivity 
Fig. 3 Vital signs of patients with PSH attack. Asterisks (*) indicate outlier points above normal limit. Gradations on X axis indicate 30 min intervals
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as well as pure sympathetic overactivity were observed, 
therefore, sometimes separated into two categories: 
pure PSH (i.e., absence of parasympathetic features) and 
mixed autonomic hyperactivity (i.e., combinations of 
sympathetic and parasympathetic overactivity) (Meyer 
2014). The cases in this report are considered to the pure 
PSH. Clinical manifestations of cases in this reports were 
paroxysmal HR of 180 beats/min, RR of 40 breaths/min, 
BP of 156 mmHg, neurogenic hyperthermia, and decer-
ebrate posturing. The paroxysms were precipitated by 
Fig. 4 a. Preoperative MRI of patient 2 showing PSH. A 7.7 cm-sized homogenous enhancing cystic and solid extraaxial mass originates form 
jugular foramen. This mass extends from retroclival area to posterior fossa compressing brainstem. (Clockwise direction; T2WI coronal, T1W enhance 
coronal, T1 W enhance axial, 3D FLAIR). b. Immediate postoperative CT scan demonstrating focal hemorrhage and edema in compressed brainstem. 
c. Postoperative CT scan (POD 14) when the PSH occurred
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afferent stimulation, a feature that has recently been con-
firmed in systemic review about PSH (Rabinstein 2004; 
Rabinstein 2007).
Clinical relevance
PSH is an important clinical problem encountering in 
critical care or rehabilitation setting of severely brain 
injured patients. The retrospective studies about progno-
sis of patients with the PSH revealed that the clinical out-
comes measured by Glasgow outcome scale (GOS) (Goh 
et al. 1999), functional independence measure, and hos-
pital length of stay (LOS) were poorer in patients with the 
PSH (Baguley et  al. 2009). Excessive sympathetic nerv-
ous system activation causes of increased potential sec-
ondary morbidities (Baguley et al. 2008; Pranzatelli et al. 
1991). Hypermetabolic state during sympathetic storms 
leads to body weight decrease estimated at 25  % in the 
acute period alone (Lemke 2007). These patients also 
have an increased likelihood of developing hyperther-
mia has been found to predict poor outcome, potentially 
as a direct cause of secondary brain damage (Rabinstein 
and Benarroch 2008; Soriano et al. 2014). Moreover, the 
prolonged hypersympathetic tone associated with the 
PSH could produce or exacerbate cardiac damage and 
elevated intracranial pressure (Rodriguez et  al. 2006; 
Tong et al. 2000). In this report, it was observed the 5 kg 
of body weight decrease during a week associated with 
the PSH. Muscle enzymes were also readily elevated after 
PSH attack.
Etiology, pathophysiology, and differential diagnosis
Several types of acquired brain injury preceding PSH 
occurrence were reviewed. The PSH was the most com-
monly associated with traumatic brain injury (79.4  %), 
followed by hypoxia (9.7  %), stroke (5.4  %), unspecified 
(1.8  %), hydrocephalus (2.6  %), tumor (0.6  %), hypogly-
cemia (0.3 %), CNS infection (0.3 %) in precedence fac-
tors order (Meyer 2014). Although the pathophysiology 
of PSH has not been fully investigated, recently brain-
stem disconnection theory has been spotlighted (Baguley 
et al. 2004). In the earliest articles of PSH, this condition 
was regarded as an epileptiform manifestation in nature 
after insults by brainstem involved lesion (Baguley et al. 
2007; Sandel et al. 1986). However, the studies that subse-
quently attempted to identify epileptiform discharges in 
PSH using electroencephalography demonstrated nega-
tive results (Gandhavadi 1988; Kao et  al. 2003; Mehta 
et al. 2008), and most antiepileptic drugs were reported 
to be ineffective in controlling the condition. As a result 
of these observations, most researchers have proposed 
a disconnection theory. This theory assumed that brain-
stem excitatory centers are released form higher control 
with a consequent sympathetic hyperactivity (Meyer 
2014). Instead, another disconnection theory, the excit-
atory-inhibitory radio model also have been posed. In 
this theory, the causative brainstem centers are inhibi-
tory in nature, and sympathetic hyperactivity originates 
at the spinal cord level analogous to autonomic dysre-
flexia following high thoracic spinal cord injury. Most 
Fig. 5 Histopathology of patient 2’s specimen (H&E stain). a. Biphasic pattern with cellar Antoni A (single asterisk) and hypocellular Antoni B (dual 
asterisk) areas. b. Schwann cell nuclei forming palisades focally and showing compact fasciles of elongated tumor cells with nuclear polymorphism. 
Based on these findings, patient was diagnosed schwannoma. (a: 40×, b: 100×)
Table 1 Diagnostic criteria of  PSH: transient presence 
of four of the six criteria without other potential causes
Clinical features
Fever Body temperature > 38.3 °C
Tachycardia Heart rate > 120 beats/min or >100 
beats/min with β-blocker
Hypertension Systolic blood pressure > 160 mmHg 
or pulse pressure > 80 mmHg
Tachypnea Respiratory rate > 30 breaths/min
Excessive diaphoresis
Extensor posturing or severe 
dystonia
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previous studies about PSH was observed in traumatic 
brain injury (79.4 %) or hypoxia (9.7 %). Only 5 cases of 
PSH were reported in tumor-related conditions, even 
they were directly midbrain involved gliomas (Goddeau 
et  al. 2007; Meyer 2014; Perkes et  al. 2010). In the case 
of tumors involving diencephalon, the pathophysiology is 
most likely an activation or a disinhibition of the central 
sympathetic regions, such as the paraventricular hypo-
thalamic nuclei, lateral periaqueductal gray substance, or 
rostral ventrolateral medulla. Sympathetic excitation has 
been demonstrated to occur in experimental neurogenic 
hypertension in which there are lesions in the hypothala-
mus or medulla. Moreover, the activation of sympathetic 
spinal or medullary reflexes, which are triggered from 
muscle mechanoreceptors and chemoreceptors during 
episodes of hypertonia, likely have a contributory role 
as well. It is important, therefore, to recognize the clini-
cal features of these autonomic episodes and to treat 
them in an appropriate fashion. In this patient the sym-
pathetic storms necessitated some form of blockade or 
suppression.
Until now, the postoperative PSH in brainstem com-
pression benign tumors were not extensively reported. 
In this report, huge petroclival chondrosarcoma (patient 
1) and jugular foramen schwannoma (patient 2) were 
compressing brainstem with edematous changes. In 
both cases, the tumors were firmly adherent to brain-
stem, as a result, some of tumors remained at brainstem 
region. Focal brainstem hemorrhage and edema were 
observed at brainstem, although, the neurologic sta-
tus was not changed relative to preoperative condition. 
After 3–4 weeks after surgery, a paroxysmal sympathetic 
hyperactivities, increasing HR, RR, BP, BT and exten-
sor posturing were observed responding to non-noxious 
stimuli. These clinical phenotypes were needed to make 
a differential diagnosis from several clinical conditions 
including seizure, hydrocephalus, encephalitis, electro-
lyte imbalance, hypoglycemia, sepsis, and spinal cord 
injury. Initially, EEG was monitored to exclude seizure, 
however, no epileptiform discharges were identified. 
In blood chemistry, electrolytes, glucose, CO2 levels 
were within normal range, and there were no evidence 
for inflammatory condition. A CT scan also showed no 
hydrocephalus. Numerous researches have proposed 
lesion locations associated with the PSH, however, the 
definite lesions induced the PSH were still elusive.
Characteristically, a number of previous studies have 
reported an association between afferent stimuli and 
sympathetic paroxysms (Bhigjee et al. 1985; Meyer 2014; 
Ryan et al. 2003; Soukup et al. 2002). Both noxious and 
non-noxious stimuli such as bathing, body position-
ing and tracheostomy care invoked a paroxysmal sym-
pathetic hyperactivity. The cumulative evidences from 
earlier studies support the contention that over-reactiv-
ity to afferent stimuli might be the hallmark of the PSH 
(Baguley et al. 1999). In our cases, the PSH was invoked 
by non-noxious stimuli such as chest percussion, wound 
dressing, and bathing. Although, the PSH subsided over 
20–30 min spontaneously, so frequently recurred that it 
could not help going untreated.
Management
Although there is a historical lack of standardized out-
come measures to evaluate treatment efficacy, previous 
studies used qualitative assessment to describe the effect 
of intervention on clinical parameters such as fewer 
paroxysms or paroxysms of reduced intensity (Bagu-
ley et  al. 2006; Boeve et  al. 1998). Several clinical tri-
als about controlling the PSH showed no effect, which 
have included hydralazine (Lemke 2007), hydroxyzine, 
diphenhydramine (Dolce et  al. 2008), trihexyphenidyl, 
and proprantheline. On the other hand, sodium amytal, 
propranolol (Rabinstein 2007), thorazine (Thorley et  al. 
2001), botulinum toxin A (Jennett et  al. 1981), codeine 
(Cuny et al. 2001), dexmedotomidine (Gandhavadi 1988), 
prazocin (Follett et al. 2003), and oxycodone (Srinivasan 
et al. 2007) have demonstrated a beneficial effect on the 
PSH. The case reports about intrathecal baclofen have 
proved an effect on the PSH, consistently. However, this 
intervention is costly, invasive, not always possible (Dool-
ing and Richardson 1976). In our cases, prazocin, pro-
pranolol, oral baclofen, benzodiazepine, and opioid were 
used to relieve the PSH. In terms of frequency and inten-
sity of the PSH, prazocin, baclofen, and benzodiazepine 
showed little effect. The propranolol, β-antagonist had 
limited effects to lower the BP, HR on acute paroxysmal 
situation, but there was no effect to prevent the attack of 
PSH. The most effectual medication was opioid patch, 
in case of intolerable condition via per os. Above all, the 
frequency of the PSH was decreased on applying the opi-
oid patch. The PSH had gradually subsided over a week. 
Despite this impressive results of opioid patch, constipa-
tion was a troublesome side effect after 2 weeks of using 
the patch. On tapering of the opioid patch, the PSH was 
recurred, therefore the patch was maintained with inter-
mittent bowel enema and bowel motility drugs (Table 2).
In addition to pharmacological intervention, there also 
appears to be a role for nutritional support relating to the 
caloric energy and replacing the insensible fluid losses 
associated with higher metabolic rate and diaphoresis 
(Baguley et al. 2007).
Natural course
The incidence of the PSH ranges from 7.7 to 33  % of 
patients with moderate or severe TBI (Baguley et  al. 
2009; Diamond et  al. 2005; Rabinstein 2004). Hypoxic 
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brain injury was the precedent etiology in 9.7–29 % of 
PSH cases (Reith et al. 1996), and a significant contribu-
tor to PSH. However, the greater incidence of TBI gives 
a higher overall prevalence of PSH. Most cases of the 
PSH reported in the literature focused on the post-TBI 
or hypoxia, consequently the natural course of the PSH 
in postoperative tumor condition was unknown. In 
severe TBI, only a small proportion of PSH cases (7 %) 
achieved a moderate or good recovery (Baguley et  al. 
2004; Rabinstein and Benarroch 2008). In our cases, the 
tumor-induced PSH was resolved within 2 months with 
medical treatment. It is not clear whether the relief 
of the PSH in our clinical setting was obtained by the 
medical management or the spontaneous resolution of 
focal hemorrhage and edema in brainstem. At immedi-
ate postoperative period, the patient 1 was stupor and 
sustained during 1  month. However, the patient was 
recovered gradually and now simple obey-command 
exam is possible and have a rehabilitation at 5 months 
after surgery. The case of patient 2 was also stupor at 
time of surgery and sustained during immediate post-
operative period. However, the patient was possible 
simple obey-command exam, now at 3  month after 
surgery.
Conclusions
A variety of acquired brain injuries such as trau-
matic brain injury (TBI) and hypoxia could cause PSH. 
Although the pathophysiology of the PSH is still elusive, 
it appears to be evident that brainstem injury is associ-
ated with the PSH. Most cases of the PSH reported to 
date occurred after TBI and hypoxia. However, the post-
operative PSH cases in benign brain tumors compress-
ing brainstem have not been reported extensively. In 
this report, the postoperative PSH in huge benign brain 
tumors compressing brainstem was effectively treated 
with opioid patch. The opioid was effective in preventing 
the PSH spell, as well as the intensity of it. The constipa-
tion was occasionally problematic, however, it could be 
controlled with intermittent enema and bowel motility 
drugs.
Patient consent
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